Mostafa M Elgebaly RPh/PhD received his PhD in cardiovascular complications of diabetes in stroke patients from the Clinical and Experimental Therapeutics Program in University of Georgia Athens, USA. He received his pharmacy license from the state of Pennsylvania in 2013.
Elgebaly MM is a fellow of both the University at Buffalo State University of New York and Novartis Pharmaceuticals where he successfully completed a joint drug-development fellowship.
Elgebaly MM research interests include biomarkers development in diabetes and acute ischemic stroke. Specially, he is interested in investigating the role of MMPs (Matrix Metallo-Proteinase) in the injury of the neurovascular unit.
Elgebaly MM has about 10 years of academic experience teaching in multiple curricular formats including semester based, 10- and 2-week quarter-based systems. He has been using online teaching technologies since 2012 to teach to remote campuses and has experience in many integrated-sequence courses within multiple areas.
Elgebaly MM is passionate about research, seeing his students grow and succeed and serving the academic community in the USA and globally. He is very excited about the MSPA program and its great potential and prospect.
Celebrating 25 years of innovation! 25.kgi.edu.